Update on Hemodialysis-Induced Multiorgan Ischemia : Brains and Beyond
Copyright © 2024 by the American Society of Nephrology..
Hemodialysis is a life-saving treatment for patients with kidney failure. However, patients requiring hemodialysis have a 10-20 times higher risk of cardiovascular morbidity and mortality than that of the general population. Patients encounter complications such as episodic intradialytic hypotension, abnormal perfusion to critical organs (heart, brain, liver, and kidney), and damage to vulnerable vascular beds. Recurrent conventional hemodialysis exposes patients to multiple episodes of circulatory stress, exacerbating and being aggravated by microvascular endothelial dysfunction. This promulgates progressive injury that leads to irreversible multiorgan injury and the well-documented higher incidence of cardiovascular disease and premature death. This review aims to examine the underlying pathophysiology of hemodialysis-related vascular injury and consider a range of therapeutic approaches to improving outcomes set within this evolved rubric..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Journal of the American Society of Nephrology : JASN - (2024) vom: 26. Jan. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
McIntyre, Christopher W [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 20.03.2024 published: Print-Electronic ClinicalTrials.gov: NCT05965934, NCT04603014, NCT04877041 Citation Status Publisher |
---|
doi: |
10.1681/ASN.0000000000000299 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367638452 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367638452 | ||
003 | DE-627 | ||
005 | 20240320234024.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240126s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1681/ASN.0000000000000299 |2 doi | |
028 | 5 | 2 | |a pubmed24n1337.xml |
035 | |a (DE-627)NLM367638452 | ||
035 | |a (NLM)38273436 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a McIntyre, Christopher W |e verfasserin |4 aut | |
245 | 1 | 0 | |a Update on Hemodialysis-Induced Multiorgan Ischemia |b Brains and Beyond |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a ClinicalTrials.gov: NCT05965934, NCT04603014, NCT04877041 | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2024 by the American Society of Nephrology. | ||
520 | |a Hemodialysis is a life-saving treatment for patients with kidney failure. However, patients requiring hemodialysis have a 10-20 times higher risk of cardiovascular morbidity and mortality than that of the general population. Patients encounter complications such as episodic intradialytic hypotension, abnormal perfusion to critical organs (heart, brain, liver, and kidney), and damage to vulnerable vascular beds. Recurrent conventional hemodialysis exposes patients to multiple episodes of circulatory stress, exacerbating and being aggravated by microvascular endothelial dysfunction. This promulgates progressive injury that leads to irreversible multiorgan injury and the well-documented higher incidence of cardiovascular disease and premature death. This review aims to examine the underlying pathophysiology of hemodialysis-related vascular injury and consider a range of therapeutic approaches to improving outcomes set within this evolved rubric. | ||
650 | 4 | |a Journal Article | |
773 | 0 | 8 | |i Enthalten in |t Journal of the American Society of Nephrology : JASN |d 1990 |g (2024) vom: 26. Jan. |w (DE-627)NLM012606502 |x 1533-3450 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:26 |g month:01 |
856 | 4 | 0 | |u http://dx.doi.org/10.1681/ASN.0000000000000299 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 26 |c 01 |